Crescent Biopharma Inc. (CBIO) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Crescent Biopharma Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$13.50
+1.73% today
Market cap
$493M
Overall quality
47/100
Kronos AI 30-day
+26.2%
8 of 8 simulated paths end higher
Crescent Biopharma Inc. (CBIO) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $493M. It trades at $13.50, up 1.73% today. Its overall quality score is 47 out of 100, ranked against the whole US market. 4 analysts' average target of $30.80 implies +128.1% from today's price. Kronos AI's 30-day forecast is +26.2% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $30.80 |
| Low – high | $27.00 – $36.00 |
| Analysts | 4 |
| Upside to average | +128.1% |
Kronos AI 30-day forecast
| Expected close | $16.75 (+26.2%) |
| Likely range | +20.5% … +32.4% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 30 |
| Solvency | 68 |
| Growth | 44 |
| Overall | 47 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.